Ignite Creation Date:
2024-05-06 @ 6:57 PM
Last Modification Date:
2024-10-26 @ 2:57 PM
Study NCT ID:
NCT05841420
Status:
RECRUITING
Last Update Posted:
2023-07-27
First Post:
2023-03-16
Brief Title:
Gemcitabine Versus Reduced-dose Combination Chemotherapy in Fragile Patients With Non-resectable Pancreatic Cancer
Sponsor:
Morten Ladekarl
Organization:
Aalborg University Hospital
Organization Data
Organization:
Aalborg University Hospital
Class:
OTHER
Study ID:
DPCG-01
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Morten Ladekarl
Lead Sponsor Class:
OTHER
Responsible Party:
Morten Ladekarl
Responsible Party Title:
Professor MD Phd
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Aalborg University Hospital
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Aarhus University Hospital | OTHER |
| Odense University Hospital | OTHER |
| Herlev and Gentofte Hospital | OTHER |
| Gødstrup Hospital | OTHER |
| Vejle Hospital | OTHER |